>>> Europe : Brokers Upgrades & Downgrades - 22nd of February 2022 V2(+)

>>> Up
* AMD Raised to Outperform at Bernstein; PT $150
* Belimo Raised to Add at Baader Helvea; PT 510 Swiss francs (+)
* BP Raised to Reduce at AlphaValue/Baader
* Nibe Raised to Equal-Weight at Morgan Stanley; PT 70 kronor
* Orsted Raised to Overweight at Barclays; PT 900 kroner
* Paragon Raised to Buy at Investec; PT 610 pence (+)
* Poste Italiane PT Raised to 15.50 euros at Barclays
* S4 Capital Raised to Buy at Numis; PT 599 pence (+)
* Spectris Raised to Buy at Peel Hunt; PT 3,470 pence
* Tenaris Raised to Add at AlphaValue/Baader
* Valiant Raised to Add at Baader Helvea; PT 110 Swiss francs
* Voestalpine Raised to Outperform at Credit Suisse; PT 43 euros

>>> Down
* Goodyear Cut to Hold at Jefferies; PT $17
* Kahoot Cut to Neutral at SpareBank; PT 30 kroner
* Lehto Group Cut to Sell at SEB Equities; PT 30 euro cents
* Pennon Cut to Underperform at Jefferies; PT 900 pence
* Severn Trent Cut to Underperform at Jefferies; PT 2,480 pence
* SSAB Cut to Neutral at Credit Suisse; PT 57 kronor
* United Utilities Cut to Hold at Jefferies; PT 1,000 pence

>>> Initiation
* Faurecia SE Reinstated Hold at Jefferies; PT 38 euros
* Nexi Rated New Equal-Weight at Morgan Stanley; PT 13 euros
* Prudential Rated New Outperform at CICC; PT 1,656.81 pence
* Seeing Machines Rated New Buy at Berenberg; PT 12 pence
* Tracsis Rated New Buy at Liberum; PT 1,335 pence (+)

>>> Call
* Citi Strategists See Investor Positioning Turning More Bearish (+)
* Beiersdorf’s Eucerin Brand is ‘Losing its Mojo,’ RBC Trims PT
* Casino Seeks Cash Lever With Mercialys Stake Sale: Bryan Garnier (+)
* Eurofins Scientific Raised Guidance Should Be Taken Well: Citi (+)
* Insatiable U.K. Housing Demand, Lack of Stock Spur Buyer Rivalry
* Nibe Risks Now Reflected in Stock, Morgan Stanley Upgrades
* SoftBank Needs to Sell More Alibaba Shares This Year: Jefferies
* Ubisoft Becoming More Reliable and Price Is ‘Reasonable:’ Citi (+)
* U.K. Water Cos. Cut at Jefferies on Regulatory and Opex Risks